Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 25;18(6):1469-1473.
doi: 10.22034/APJCP.2017.18.6.1469.

Cholangiocarcinoma: New Insights

Vedat Goral  1
Affiliations
Review

Cholangiocarcinoma: New Insights

Vedat Goral. Asian Pac J Cancer Prev. .

Abstract

Cholangiocarcinoma is a malignant neoplasm originating from biliary epithelial cells. The incidence and mortality of this cancer are rising in the world. Currently, cholangiocarcinoma is accepted as a stem cell disease with many risk factors. Diagnosis is relatively simple but therapy is extremely difficult. Surgery is the mainstay of treatment for early stage patients. Endobiliary approaches, chemotherapy and radiotherapy are other therapeutic approaches.

Keywords: Cholangiocarcinoma; stem cell disease; pathogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bismuth- Corlette Classification in Perihilar Cholangiocarcinoma (From: Razumilava N. 2012).
Diagram 1
Diagram 1
Etiopathogenetic Mechanism in CC, Etiologic Agents and Cholangiocyte Response to Damage (From: Dalbir S. Liver Int 2008).
Figure 2
Figure 2
a) Choledocal Narrowing in ERCP b) Mass in Intraductal USG c) Malign Cytology (From: Weber A. 2008).
Figure 3
Figure 3
In Cholangioscopy a) Normal Bile Duct b) Mass in Bile Duct (From:Wakai T. 2005)
See this image and copyright information in PMC

References

    1. Andersen JB, Thorgeirsson SS. Genetic profilling of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol. 2012;28:266–72. - PMC - PubMed
    1. Boris RA, Blechacz Gregory JG. Cholangiocarcinoma. Clin Liver Dis. 2008;12:131–150. - PubMed
    1. Blechaz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;2:512–22. - PMC - PubMed
    1. Croitoru A, Gramaticu I, Dinu I, et al. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma-a retrospective study. J Gastrointestin Liver Dis. 2012;21:277–84. - PubMed
    1. De Minics S, Kisselva T, Francis H. Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma. Dig Liver Dis. 2013;45:450–9. - PMC - PubMed